Sébastien Gibot

Professor Sébastien GIBOT is co-founder of INOTREM. Prof. Sébastien Gibot is Professor of Intensive Care Medicine at Hopital Central, Nancy, France. He managed Dr Marc Derive’s thesis and thus co-developed anti-sepsis compounds. Prof. Sébastien Gibot has over 15 years’ experience of fundamental and clinical research in the field of immunotherapy of sepsis. He authored 67 peer reviewed papers and has 4 patents in the field. Prof. Sébastien Gibot is known and recognized as the international specialist of TREM-1 and he is largely implicated in the scientific and development activities of INOTREM Company.